SHALINI SANGAL: Open Payments
NPI 1689660896 · WAGONER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 34 payments from 5 companies in 2025. Trend: 2023 $690 · 2024 $628 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $165 |
| Alkermes, Inc. | 9 | $141 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
Products named: COBENFY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across OK — which companies pay providers there.
